Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
golimumab (simponi) (1 trial)
autologous adipose-derived mesenchymal stem cells (1 trial)
fluorouracil (efudex) (1 trial)
mitomycin (mutamycin) (1 trial)
panitumumab (vectibix) (1 trial)
trifolium pratense (1 trial)
oxygen (1 trial)
Anus Neoplasms (Phase 2)
Carcinoma (Phase 2)
Carcinoma, Squamous Cell (Phase 2)
Colitis (Phase 4)
Colitis, Ulcerative (Phase 4)
Conjunctivitis (Phase 2)
Ulcer (Phase 4)
Trials (5 total)
Trial APIs (7 total)